Public trial registry of the CCC-Munich

Trial BAY VOYAGER PAD

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
BAY VOYAGER PAD
World
Full title
:

An international, multicenter, randomized, double-blind, placebocontrolled phase 3 trial investigating the efficacy and safety of rivaroxaban to reduce the risk of major thrombotic vascular events in patients with symptomatic peripheral artery disease undergoing lower extremity revascularization procedures

World
Responsible organization
:
Gefäßchirurgie TUM Isamninger Straße 22 81675 München Deutschland Tum
Indications
Classification Code Description
- I70.2 Atherosklerose der Extremitätenarterien
Trial design
World
Phase
:
III
Status
World
Status
:
Recruitment active
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Chirurgisch

Participants
Function Prename Surname Organization
World Responsible contact Hans-Henning Eckstein Gefäßchirurgie TUM Isamninger Straße 22 81675 München Deutschland Magnifier